NewLimit
NewLimit is a biotechnology company focusing on developing epigenetic reprogramming therapies that aid with illnesses that are normally associated with aging.
1
Funding Rounds
$40.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ki**** | - | - | |
| Br*** Ar******* | - | - | linkedin twitter facebook instagram |
| Gr***** Jo***** | - | - | |
| Bl*** By*** | - | - | linkedin twitter |
Funding series
Funding Series Analysis
The company NewLimit has raised a total of $40m in funding over 1 rounds.
Key Insights:
- NewLimit Series A round, May 16, 2013: $40m
NewLimit Series A round, May 16, 2013
$40m
Industries
NewLimit is active in the following industries:
- Machine learning
- Anti-Aging
- Biotechnology